α-甲基-DL-苯丙氨酸甲酯盐酸盐 | 64665-60-7

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 苯丙氨酸类衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: α-甲基-DL-苯丙氨酸甲酯盐酸盐
• 中文别名: Α-甲基-DL-苯丙氨酸甲酯盐酸盐
• 英文名称: DL-α-methylphenylalanine methyl ester hydrochloride
• 英文别名: rac-α-MePheOMe*HCl；2-amino-2-methyl-3-phenyl-propionic acid methyl ester; hydrochloride；2-Amino-2-methyl-3-phenyl-propionsaeure-methylester; Hydrochlorid；α-methyl-dl-phenylalanine methyl ester hydrochloride；Methyl 2-amino-2-methyl-3-phenylpropanoate hydrochloride；methyl 2-amino-2-methyl-3-phenylpropanoate;hydrochloride
• CAS: 64665-60-7
• 化学式: C₁₁H₁₅NO₂*ClH
• 分子量: 229.707
• InChiKey: VUYGLGCVKCLWPY-UHFFFAOYSA-N

物化性质

• 熔点：
  138-143 °C

计算性质

• 辛醇/水分配系数(LogP)：
  1.54
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  52.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 安全说明：
  S22,S24/25
• WGK Germany：
  3
• 海关编码：
  2922499990
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  -20°C

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
: α-Methyl-DL-phenylalanine methyl ester
Product name
hydrochloride
CAS-No. : 64665-60-7
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
Not a hazardous substance or mixture according to EC-directives 67/548/EEC or 1999/45/EC.
Label elements
Caution - substance not yet tested completely.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Synonyms : (±)-Methyl 2-amino-2-methyl-3-phenylpropionatehydrochloride
Formula : C11H15NO2 · HCl
Molecular Weight : 229,7 g/mol

---

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx), Hydrogen chloride gas
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: -20 °C
Store under inert gas. Moisture sensitive.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: powder
Colour: white
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 138 - 143 °C
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

---

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  α-甲基-DL-苯丙氨酸甲酯盐酸盐 在 palladium on activated charcoal 氢气 、 硝酸 作用下， 以 甲醇 、 乙酸酐 、 苯 为溶剂， -15.0 ℃ 、303.98 kPa 条件下， 反应 1.5h， 生成 methyl 2-formamido-3-(4-formamido-3-nitrophenyl)-2-methylpropanoate
  参考文献：
  名称：

  FR2340729

  摘要：

  公开号：
• 作为产物：
  描述：

  methyl 2-(benzylideneamino)-3-phenylpropionate 、 O1,O2,O5,O6-diisopropylidene-O3-methoxysulfonyl-α-D-glucofuranose 在 六甲基磷酰三胺 、 lithium diisopropyl amide 作用下， 生成 α-甲基-DL-苯丙氨酸甲酯盐酸盐
  参考文献：
  名称：

  Enantioselective electrophilic bond construction to the α-carbon of α-aminoacids

  摘要：

  DOI：

  10.1016/s0040-4020(01)86055-5

文献信息

• [EN] BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] INHIBITEURS DE BENZYLETHER ET BENZYLAMINO DE BETA-SECRETASE POUR TRAITER LA MALADIE D'ALZHEIMER
  申请人：MERCK & CO INC

  公开号：WO2005051914A1

  公开（公告）日：2005-06-09

  The present invention is directed to benzylether and benzylamino derivative compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及苯乙醚和苄胺衍生物化合物，这些化合物是β-分泌酶的抑制剂，并且在治疗涉及β-分泌酶的疾病，如阿尔茨海默病中有用。该发明还涉及包含这些化合物的药物组合物，以及在治疗涉及β-分泌酶的这类疾病中使用这些化合物和组合物。
• Novel and Expeditious Microwave-Assisted Three-Component Reactions for the Synthesis of Spiroimidazolin-4-ones
  作者：Ping Ye、Katie Sargent、Ethan Stewart、Ji-Feng Liu、Daniel Yohannes、Libing Yu

  DOI：10.1021/jo060228q

  日期：2006.4.1

  Highly efficient methods for the syntheses of spiroimidazolinones via microwave-assisted three-component one-pot sequential reactions or one-pot domino reactions are described. The efficiency and utility of the methods have been demonstrated by quickly accessing the antihypertensive drug irbesartan (2).

  描述了通过微波辅助三组分一锅法或一锅多米诺反应合成螺氨基咪唑啉酮的高效方法。通过快速使用降压药厄贝沙坦（2）已证明了该方法的有效性和实用性。
• Metallkomplexe von biologisch wichtigen Liganden, CXXIX [1]. Palladium(II)-und Platin(II)-Komplexe von 4,4-disubstituierten Oxazolonen und C2-symmetrischen Bis(oxazolonen) Metal Complexes of Biologically Important Ligands, CXXIX [1]. Palladium(II) and Platinum(II) Complexes of 4,4-Disubstituted Oxazolones and of C₂-Symmetric Bis(oxazolones)
  作者：Werner Bauer、Walter Ponikwar、Wolfgang Beck

  DOI：10.1515/znb-2000-1009

  日期：2000.10.1

  4H)-oxazolone (1) forms with the chloro bridged compounds [R3PMCl2]2 (M = Pt, Pd) the complexes Cl2Pt(PR3)(l) (R = Et, nBu) and Cl2Pd(PEt3)(l). The enantiomeric pure C2-symmetric CMe2 bridged bis(oxazolones) 5 and 6 have also been employed which give with PdCl2 the chelate complexes 13 and 14. The X-ray structural determination of Cl2P d[O-C (O)-CMe2-N=C-CMe2-C=N-CMe2-C (O)-O ] (10) shows that one

  摘要 4-Benzyl-4-methyl-2-phenyl-5(4H)-oxazolone (1) 与氯桥化合物 [R3PMCl2]2 (M = Pt, Pd) 形成配合物 Cl2Pt(PR3)(l) (R = Et, nBu) 和 Cl2Pd(PEt3)(l)。还使用了对映体纯 C2-对称 CMe2 桥连双（恶唑酮）5 和 6，它们与 PdCl2 形成螯合物 13 和 14。 Cl2P d[OC (O)-CMe2-N=C 的 X 射线结构测定-CMe2-C=N-CMe2-C (O)-O ] (10) 表明 CMe2 桥的甲基之一位于钯原子附近。这也可以在 1H NMR 谱中检测到。
• Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
  申请人：Nantermet G. Philippe

  公开号：US20070088165A1

  公开（公告）日：2007-04-19

  The present invention is directed to benzylether and benzylamino derivative compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及式(I)的苯甲醚和苯甲氨基衍生物化合物，它们是β-分泌酶酶的抑制剂，并且在治疗β-分泌酶酶涉及的疾病，例如阿尔茨海默病中有用。本发明还涉及包含这些化合物的制药组合物以及在治疗β-分泌酶酶涉及的疾病中使用这些化合物和组合物的用途。
• Substituted N-(imidazolyl)alkyl alanine derivatives
  申请人：SMITHKLINE BEECHAM CORPORATION

  公开号：EP0427463A1

  公开（公告）日：1991-05-15

  Angiotensin II receptor antagonists having the formula: which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.

  式的血管紧张素 II 受体拮抗剂： 用于调节高血压和治疗充血性心力衰竭、肾功能衰竭和青光眼的血管紧张素 II 受体拮抗剂，包括这些拮抗剂的药物组合物，以及使用这些化合物在哺乳动物体内产生血管紧张素 II 受体拮抗作用的方法。